Protect Patients. Infuse Life.
We’re Advancing Clinical Care
HAI Solutions (HAIS) believes in protecting every patient by building innovative medical devices which address the challenges and pitfalls associated with Intravenous Care and Vascular Access. We are advancing clinical care across the healthcare spectrum targeting Intravenous Contamination.
We understand workflows are arduous, time-consuming, and don’t eliminate the problem. Patient care is demanding and healthcare-associated continue to be a $15K to $30K cost per incident. We are simplifying clinical workflow with innovative technologies that support all segments of the healthcare continuum.
Our Solutions
We are developing a unique portfolio of medical devices that addresses the growing plague of contamination within the Operating Room, Emergency Room, and Intensive Care Units. Our platform of innovative vascular access technology targets Hospital Onset Bactermia (HOB) and Microbial Contamination (MC).
-
QIKcap System™
The First and Only FDA Granted - Ultraviolet light-based microbial reduction device for needleless IV connectors.
-
Multiport Delivery Device™
Our novel Multiport Delivery Device™ is designed to improve and simplify induction of anesthesia. Not yet reviewed or cleared by the FDA.
Awards and Accolades
Our Commitment
Preventing Microbial Contamination (MC) is a top priority for CDC and its partners in public health and healthcare. Our Team is committed to supporting patients and healthcare professionals!
HAIS News
Clinical Organizations We Follow
Advancing Clinical Care
More than 300 Million IV lines are placed each year in the United States and 1 in 31 patients will acquire a catheter-related blood infection. Our Solutions are designed to meet the challenging needs any patient encounters via their Peripheral, PICC, Central vascular access line and Dialysis line.